Education
Recorded live at the ADA Conference in Orlando, Florida.
Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes.
Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn how Omnipod 5 has performed in real-world settings, and why having this data can help personalize diabetes care by understanding how different patient demographics can benefit from tubeless AID technology.
------------
Dr. Greg Forlenza is an endocrinologist. Dr. Forlenza has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.